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a b s t r a c t
Myoblast fusion (a critical process by which muscles grow) occurs in a multi-step fashion that requires
actin and membrane remodeling; but important questions remain regarding the spatial/temporal
regulation of and interrelationship between these processes. We recently reported that the Rho-GAP,
GRAF1, was particularly abundant in muscles undergoing fusion to form multinucleated ﬁbers and that
enforced expression of GRAF1 in cultured myoblasts induced robust fusion by a process that required
GAP-dependent actin remodeling and BAR domain-dependent membrane sculpting. Herein we devel-
oped a novel line of GRAF1-deﬁcient mice to explore a role for this protein in the formation/maturation
of myotubes in vivo. Post-natal muscles from GRAF1-depleted mice exhibited a signiﬁcant and persistent
reduction in cross-sectional area, impaired regenerative capacity and a signiﬁcant decrease in force
production indicative of lack of efﬁcient myoblast fusion. A signiﬁcant fusion defect was recapitulated in
isolated myoblasts depleted of GRAF1 or its closely related family member GRAF2. Mechanistically, we
show that GRAF1 and 2 facilitate myoblast fusion, at least in part, by promoting vesicle-mediated
translocation of fusogenic ferlin proteins to the plasma membrane.
& 2014 Published by Elsevier Inc.
Introduction
Myogenesis occurs through the fusion of singly nucleated
myoblasts into multinucleated myotubes and this process is
essential for proper skeletal muscle formation and injury repair.
It is becoming clear that dynamic and coordinated changes in actin
polymerization and vesicle trafﬁcking are required for skeletal
muscle formation. For example, formation and subsequent dis-
solution of an F-actin focus at the distal ends of fusion competent
myoblasts is essential for myoblast-myoblast fusion (Peckham,
2008; Schafer et al., 2007; Schroter et al., 2004; Swailes et al.,
2004). The dissolution of actin is thought to be important for
promoting intercellular lipid bilayer fusion and perhaps for the
recruitment of unilamellar vesicles that deposit essential fusogenic
proteins and phospholipids (Kalderon and Gilula, 1979), but the
molecular machinery that orchestrate coordinated changes in
vesicular trafﬁcking and actin dynamics remain elusive.
Myoferlin and its family members (dysferlin and Fer1L5) are
large membrane anchored proteins that contains six to seven
calcium response domains (so-called C2 domains) and their
structures closely resemble that of synaptotagmins, proteins that
facilitate fusion of membrane-bound vesicles to the plasma mem-
brane during exocytic neurotransmitter release (Martens et al.,
2007). Dysferlin-deﬁciency is causal for Limb girdle muscular
dystrophy 2B, and studies in muscle ﬁbers lacking dysferlin
revealed defects in membrane resealing following mechanical or
laser-induced membrane rupture (Bansal et al., 2003; Han and
Campbell, 2007). The ﬁnding that dysferlin-null muscle retained
accumulation of vesicles near membrane damage sites indicates
that dysferlin likely mediates the ﬁnal step of fusion necessary for
plasma membrane repair (Posey et al., 2011b). Myoferlin and
Fer1L5 which are transiently expressed during myogenesis and
are known to facilitate myoblast fusion during the development of
nascent muscle ﬁbers likely function in a similar fashion. Ferlins
are only transiently expressed on muscle plasma membranes and
their active recruitment to the sarcolemma is tightly regulated by
endocytic recycling mediated by the Eps15 homology domain
(EHD)-containing proteins 1 and 2 (Cai et al., 2009a; Doherty
et al., 2008; Posey et al., 2011a, 2011b). While several muscular
dystrophies are associated with abnormal plasma membrane
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localization of dysferlin, indicating the signiﬁcance of this regula-
tory process (Cai et al., 2009b; Evesson et al., 2010; Matsuda et al.,
2001; Wallace and McNally, 2009), the precise mechanisms that
govern ferlin recruitment during myoblast fusion or to sites of
injury are still poorly understood.
We recently identiﬁed a striated muscle enriched protein
termed GRAF1 that is poised to co-regulate actin- and lipid-
dynamics by virtue of its multi-domain structure that includes a
N-terminal lipid binding/bending BAR domain, a phosphatidyl
serine (PS)-binding PH domain, a central Rho-GAP domain, and a
C-terminal protein-interaction SH3 domain that interacts with
focal adhesion kinase (FAK) (Hildebrand et al., 1996; Taylor et al.,
1998, 1999). We reported that depletion of GRAF1 from developing
tadpoles induced a highly penetrable dystrophic phenotype that
that led to immobility (Doherty et al., 2011). Moreover, we showed
that ectopic expression of GRAF1 in cultured myoblasts induced
robust fusion by a process that required both GAP-dependent actin
remodeling and BAR domain-dependent membrane binding or
sculpting. However, since myoblast fusion does not occur in
developing tadpoles, questions remained as to whether (or to
what extent) GRAF1 was necessary for myoblast fusion in vivo. We
developed a novel line of GRAF1 deﬁcient mice and our studies
detailed herein reveal that while viable, these mice exhibit limited
myogenesis. Moreover, our mechanistic studies reveal that GRAF1
and its related family member, GRAF2, regulate myoblast fusion by
promoting endocytic recycling-dependent membrane recruitment
of the fusogenic ferlin proteins to the plasma membrane.
Materials and methods
Generation of GRAF1 gene trap mice
GRAF1 gene trap mice were generated and obtained from the
Texas A&M Institute for Genomic Medicine (College Station, TX)
using the OmniBank ES cell clone OST135790 which harbors the
gene trapping vector VICTR48 within the ﬁrst intron of Graf1
(Arhgap26, accession #: NM_175164). To generate a stable mutant
mouse line, 129SvEv-derived ES cells were microinjected into host
C57BL/6J mice for germline transmission of the GRAF1mutation. All
experimental mice were maintained on a mixed 129/SvEv-C57BL/6J
genetic background. Mice were genotyped utilizing the following
primers: forward Primer A (5-AGCACTGTGAACACCATTCTG-30),
forward Primer C (50-AAATGGCGTTACTTAAGCTAGCTTGC-30), and
reverse Primer B (50-AAAGGACATCTGACACTACCAAA-30). Animals
were treated in accordance with the approved protocol of the
University of North Carolina (Chapel Hill, NC) Institutional Animal
Care and Use Committee, which is in compliance with the standards
outlined in the guide for the Care and Use of Laboratory Animals.
Primary antibodies and cDNA constructs
Commercial antibodies were purchased from Sigma (laminin,
tropomyosin (CH1) and monoclonal γ-tubulin); Abcam (EHD2,
Lamp2 and Thy-1); BD Biosciences (GM130 and Rab5); Epitomics
(EHD1); Cell Signaling (Myc-tag, 9B11); GAPDH (Imgenex); Novus
Biologicals (myoferlin); and Developmental Studies Hybridoma
Back, Univ. of Iowa (MHC, NA4). The GRAF2 (PS-GAP) antibody was
a generous gift from Dr. Wen-Cheng Xiong (Georgia Regents
University, GA) (Ren et al., 2001). Derivation of the polyclonal
Fer1L5 and GRAF1 antibodies was previously described (Doherty
et al., 2011; Posey et al., 2011b). A hamster monoclonal GRAF1
antibody was designed in house using the identical peptide
immunogen by standard methodology. The GRAF1loxP cDNA con-
struct was described (DiMichele et al., 2009; Doherty et al., 2011).
Brieﬂy, Myc-tagged GRAF1 was subcloned into a Cre recombinase-
inducible construct, downstream of a beta-actin promoter and a
GFP reporter followed by a transcriptional ‘stop’ site ﬂanked as a
unit by loxP sites. As such, the GRAF1loxP construct allows for Cre-
dependent expression of GRAF1 in a time-dependent manner. The
Ad5CMV Cre recombinase adenovirus was purchased from the
University of Iowa Gene Transfer Vector Core (Iowa City, IA), and
the Ad5CMV LacZ adenovirus was purchased the University of
North Carolina Viral Core (Chapel Hill, NC).
Semi-quantitative RT-PCR analysis
Total RNA was isolated from homogenized whole mouse tissues
or primary mouse myoblast cultures using RNeasy Mini Kit
(Qiagen) according to manufacturer's instructions. Complimentary
DNA (cDNA) was obtained from 1 mg of RNA isolated using the
iScript cDNA Synthesis Kit (Bio-Rad,), and PCR ampliﬁcations of 30
cycles were performed using 2.5% of total synthesized cDNA
and TaKaRa Ex Taq Polymerase (Millipore) according to manufac-
turer's instructions using the following primers graf1 forward
50-TGGAAGGGTACCTGTACGTG-30 and graf1 reverse 50-ATCCCG-
TTGGTAGGTACAGT-30, Ta¼60 1C; graf2 forward 50-TAACAGTCATAT-
GAAGATTTTTCGAACCTCGCCTG-30 and graf2 reverse 50-CTGATG-
GATCCTTATGCCCGAGCCTTTCGATTGAT-30, Ta¼56 1C (Koeppel et al.,
2004); skeletal alpha actin forward 50-CAGAGCAAGCGAGGTATCC-30
and skeletal alpha actin reverse 50-GTCCCCAGAATCCAACACG-30,
Ta¼50 1C; and gapdh forward 50-ATGGGTGTGAACCACGAGAA-30
and gapdh reverse 50-GGCATGGACTGTGGTCATGA-30, Ta¼43 1C.
RT-PCR products were analyzed by electrophoresis using 2.0%
agarose gels.
Cell culture, transfection and siRNA treatment
Primary myoblasts were maintained in growth media (GM;
Dulbecco's modiﬁed Eagle's medium (DMEM) supplemented with
20% fetal bovine serum (FBS), 10% horse serum (HS) and penicillin/
streptomycin). C2C12 mouse myoblasts obtained from ATCC
(Catalog number CRL-1772) were maintained in DMEM supple-
mented with 10% FBS and antibiotics. C2C12 cells maintained in
GM were transfected with Myc-tagged GRAF1 cDNA or GRAF1loxp
cDNA using TransIT transfection reagent (Mirus) according to
manufacturer's instructions. Myoblasts were infected with Cre- or
LacZ-expressing adenoviruses at 100 multiplicities of infection.
For differentiation, myoblasts were plated on Lab-Tek CC2 chamber
slides or plastic dishes pre-coated with rat tail collagen, Type I
(10 μg/ml) and transferred to differentiation medium (DM; DMEM
containing 2% HS). In some instances, myoblasts were treated with
brefeldin A (Sigma) at indicated concentrations 12 h prior to
ﬁxation. GRAF1 and GRAF2 were depleted from cultured myoblasts
using short interfering RNA (siRNA) duplex oligoribonucleotides
obtained from Invitrogen with the following sequences: graf1a
sense 50-GCAGCUGUUGGCCUAUAAU(dT)(dT)-30 and anti-sense
50-AUUAUAGGCCAACAGCUGC-30; graf1b sense 50-AAGUGGACCUG-
GUUCGGCAACAUUU-30 and anti-sense 50-AAAUGUUGCCGAACCAG-
GUCCACUU-30; and graf2 sense 50-CAAAGGUCCAGAGACUUCU-
GAGUAU-30 and anti-sense 50-AUACUCAGAAGUCUCUGGAC-
CUUUG-30. Myoblasts maintained in GM or DM were transfected
with 150 nM of total gene-speciﬁc siRNA (GRAF1 was knocked
down using 75 nM of both graf1a and graf1b, GRAF2 was knocked
down using 150 nM of graf2, double depletion of GRAF1 and GRAF2
required 37.5 nM each of graf1a and graf1b and 75 nM of graf2, and
150 nM of a GFP-speciﬁc siRNA was used as a non-target control
(NTC) using DharmaFECT reagent 1 according to manufacturer's
instructions (Thermo Scientiﬁc)). In some experiments, 50 nM of
Block-IT red ﬂuorescent oligonucleotides (Invitrogen) was conco-
mitantly transfected with the siRNAs to assess transfection
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efﬁciency. After 8 h, media was exchanged and cells were ﬁxed or
snap-frozen at indicated time points.
Primary myoblast isolation
Skeletal muscle from GRAF1gt/gt and GRAF1þ /þ littermates was
meticulously isolated from 3–4 P2 neonatal mouse pups per
genotype and placed in ice-cold PBS. Once all tissue was harvested,
the PBS was exchanged for Hank's Balanced Salt Solution (HBSS;
GIBCO) and tissue was transferred to a sterile 100 mm petri dish
for mincing using a sterile razor blade in minimal HBSS. Tissue was
digested using 0.2% Collagenase, Type II (Worthington Biochem-
icals) in HBSS incubated at 37 1C for 40 min, brieﬂy swirling every
10 min during incubation. Digested muscle was triturated 5 times
using a wide-mouth pipette and ﬁltered through a 100 mm nylon
mesh cell strainer (BD Biosciences). The cell suspension was then
incubated at room temperature for 1 h followed by addition of
30 mL GM and centrifuged at 2000 rpm for 3 min. Cells were pre-
plated in GM for 45 min and the remaining suspension was gently
transferred to new 100 mm dishes at 1106 cells/dish and
incubated undisturbed for 72 h prior to use.
Myoblast differentiation and fusion assays
Myoblasts were seeded at subconﬂuent densities on collagen-
coated slides in GM and after 12 h switched to DM for indicated
time. The differentiated index, fusion index, and number of nuclei
per ﬁeld were quantiﬁed as described previously, with slight
modiﬁcations (Jansen and Pavlath, 2006). Brieﬂy, the differentia-
tion index is deﬁned as the ratio of number of nuclei in Tm-
positive cells to total number of nuclei counted, while the fusion
index is deﬁned as the ratio of number of nuclei in myotubes (Z2
nuclei) to total nuclei counted. Images were analyzed using ImageJ
software (NIH) to measure the long axis of the cell and cross-
sectional cell perimeter.
Immunohistochemistry and immunocytochemistry
Upon harvest, tissues were immediately embedded in Tissue-
Tek O.C.T. compound (Sakura), snap-frozen in 2-methylbutane
cooled over dry ice, and cross-sectioned at 8 mm using a cryotome.
Sections were post-ﬁxed (or cultured myoblasts were ﬁxed) in 4%
paraformaldehyde, permeabilized, and stained using standard
techniques. The GRAF2, tropomyosin, MHC, Myc-tag, and myofer-
lin antibodies were diluted at 1:500; The GRAF1, EHD1, EHD2, and
Fer1L5 antibodies were diluted at 1:200; The Lamp2 and GM130
antibodies were diluted at 1:100; and the Rab5 antibody was
diluted at 1:50. A mouse anti-hamster linker (SouthernBiotech)
was used at 1:500 for conjugation to the GRAF1 hamster antibody.
Cells/tissues were then incubated with Alexa Fluor secondary
antibodies (Invitrogen), Alexa Fluor phalloidin (Invitrogen), Alexa
Fluor wheat germ agglutinin (Invitrogen) and DAPI at 1:500 in PBS
for 1 h, washed and mounted.
Muscle injury model and in vivo myoﬁber analysis
Gastrocnemius and diaphragm muscles were harvested from
4 month old GRAF1gt/gt and GRAF1þ /þ littermates and processed
as described previously. To induce muscle injury, 100 mL of 20 mM
cardiotoxin (Naja nigricollis, Calbiochem) was injected into the
gastrocnemius muscle of 4 month old littermates. Muscles were
harvested 3, 14 and 28 days post-injury and processed as
described. Images were acquired and analyzed using ImageJ soft-
ware to quantify myoﬁber cross sectional area. The in vivo fusion
index was quantiﬁed as described previously (Hochreiter-Hufford
et al., 2013). Brieﬂy, the in vivo fusion index is described as the
ratio of number of myoﬁbers with Z2 centrally located nuclear
foci to total number of regenerating myoﬁbers.
Fluorescence ratio analysis
The EHD1 ﬂuorescence ratio is deﬁned as the ratio of the EHD1
signal within a pre-fusion complex (10 mm2 yellow box, Fig. 8f) to
the EHD1 signal within the remainder of the cell. Integrated
density values obtained using ImageJ were used in the calculation
of EHD1 ﬂuorescence ratios. Tm-positive cells which contained
1 or 2 nuclei, and exhibited an elongated phenotype with a
prominent pre-fusion complex were imaged using a Zeiss 710
confocal microscope set to a 2 mm pinhole.
Protein isolation, western blotting and co-immunoprecipitation
Tissue samples were snap-frozen in liquid nitrogen, sonicated
in modiﬁed radioimmune precipitation assay (RIPA) buffer
(50 mM HEPES pH 7.2, 0.15 M NaCl, 2 mM EDTA, 0.1% Nonidet
P-40, 0.05% sodium deoxycholate, 0.5% Triton X-100 plus 1 mM
sodium orthovanadate and 1 concentrations of both Halt Pro-
tease Inhibitor Cocktail (Thermo Scientiﬁc) and Halt Phosphatase
Inhibitor Cocktail (Thermo Scientiﬁc)), and cleared by centrifuga-
tion. Cultured C2C12 mouse myoblasts were directly lysed and
cleared in RIPA buffer. For immunoprecipitation studies, 1 mg of
cleared lysate was incubated with 10 mg of either an anti-GRAF1
antibody (polyclonal) or the corresponding non-immune sera
(NIS) overnight at 4 1C. The solution was then mixed with 75 mL
of a 50% slurry of Protein A Sepharose beads (Sigma) in TBS and
rotated at 4 1C for 2 h. Beads were then quickly tapped down in a
refrigerated centrifuge and rinsed 3 times with ice-cold
RIPAþ inhibitors and once with TBS before beads were boiled in
50 mL of sample buffer. Lysates were resolved by SDS-PAGE,
transferred to nitrocellulose membranes, and immunoblotted with
antibodies at 1:1000 dilutions using standard techniques.
Microscopy
Cells and tissue sections were examined by confocal micro-
scopy using a Zeiss CLSM 710 Spectral Confocal Laser Scanning
Microscope. Confocal Z-stack images were obtained and 3D
images were reconstructed using IMARIS software.
Statistical analyses
All statistical analyses were performed using Student's t-test.
Data are expressed as mean7s.e.m. and p-values o0.05 were
considered statistically signiﬁcant. Western blots were performed
three separate times with representative images shown. Cellular
phenotypes were scored from three independent experiments.
Results
Generation of GRAF1 deﬁcient mice
To explore a role for GRAF1 in promoting myoblast fusion
in vivo, we generated a GRAF1 deﬁcient mouse line using ES cells
that contained an inhibitory gene trap within the ﬁrst intron of
Graf1 (Fig. 1a). Crosses between GRAF1þ /gt mice yielded offspring
in the appropriate Mendelian ratios as assessed by validated PCR
genotyping (Fig. 1b and Supplementary Table S1). GRAF1 was
strongly but not completely depleted in all tissues evaluated
indicating that our model results in a hypomorphic allele. Impor-
tantly, GRAF1 mRNA levels and protein were virtually undetect-
able in all skeletal muscle types evaluated (gastrocnemius,
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quadriceps femoralis, triceps, and diaphragm) supporting the
value of this model to further investigate a role for GRAF1 in
the development and maintenance of these tissues (Fig. 1c).
As previously reported, GRAF1 is also highly expressed in the
brain and while a signiﬁcant reduction in message and protein was
observed therein, some residual expression did remain. The tissue-
speciﬁc differences in residual GRAF1 mRNA levels in the GRAF1gt/gt
mice were likely due to the differential expression or activity of
splicing factors (Braunschweig et al., 2013).
GRAF1 is necessary to promote proper muscle growth in vivo
No overt phenotypes were observed in GRAF1þ /gt or GRAF1gt/gt
mice for up to 1 year, though a modest reduction in body weight
was observed in young adult homozygous mutant mice (27.2þ/
1.0 g versus 24.3þ/1.6 g; p¼0.13 at 4 months of age). To
determine if GRAF1 is necessary for efﬁcient muscle growth, we
quantiﬁed the cross sectional area (CSA) of different muscle types.
As shown in Fig. 2, the distribution of ﬁber size showed a relative
lack of large myoﬁbers and more small ﬁbers in GRAF1gt/gt
diaphragm and gastrocnemius muscles compared to littermate
controls. Concomitantly, mean ﬁber size of both muscles types
were signiﬁcantly smaller in GRAF1gt/gt mice than in littermate
controls. Since myoﬁber CSA is known to correlate with force
production, we next measured the grip force of GRAF1þ /þ and
GRAF1gt/gt mice using a digital strain gauge (Qiao et al., 2008).
Conﬁrming an important role for GRAF1 in muscle formation, we
found that GRAF1gt/gt mice exhibited a signiﬁcant reduction in grip
strength compared to GRAF1þ /þ mice (137.9þ/6.2 N versus
151.2þ/6.8 N respectively; po0.05). No signiﬁcant difference
in levels of differentiation markers were observed in P1 or P10
muscles, indicating that the muscle development defect was likely
due to impaired muscle fusion, not differentiation (Supplemental
Fig. S1a).
Besides its importance in formation of large muscle ﬁbers
during development, myoblast fusion plays a key role in the
regeneration of injured muscle. To determine if GRAF1 might also
function in this setting, we treated Wt mice with cardiotoxin and
evaluated GRAF1 expression 3, 14, and 28 days later. We found that
while GRAF1 was expressed at very low levels in un-injured adult
muscle, GRAF1 was transiently increased at early stages of muscle
regeneration particularly within the smaller nascent myotubes
that were most abundant 3 days following injury. To explore a
functional role for GRAF1 in mediating fusion during muscle
regeneration, we quantiﬁed nuclear accretion and growth in
regenerating Wt and GRAF1gt/gt muscles 14 and 28 days post-
injury. As shown in Fig. 3b, a signiﬁcant reduction in the average
number of nuclei was observed in regenerating GRAFgt/gt myoﬁ-
bers compared to GRAF1þ /þ littermates. Moreover, after 14 days,
the GRAF1gt/gt mice exhibited a signiﬁcant reduction in the
number of regenerating myoﬁbers with two or more nuclear foci
(in vivo fusion index) (Fig. 3c and d; Supplemental Fig. S2a). This
reduction in nuclear foci persisted to 28 days post-injury and a
concomitant signiﬁcant reduction in the CSA of the regenerating
myoﬁbers was observed at this time point (Fig. 3d and e;
Supplemental Fig. S2b and c). Importantly, we found no signiﬁcant
difference between these groups (75.9279.67 vs. 80.8875.77,
p¼0.33), indicating that the signiﬁcantly reduced muscle recovery
was not likely due to exacerbated injury in this model. Collectively,
these data indicate that GRAF1 is required for optimal fusion and
growth of myoﬁbers during development and following injury.
To conﬁrm and extend these ﬁndings, we next compared the
fusion capabilities of myoblast cultures isolated from the hindlimb
muscles of P2 GRAF1gt/gt and GRAF1þ /þ littermates. Cells were
plated at high density and subjected to differentiation media (DM)
to induce myotube formation. While no signiﬁcant difference
was observed in the differentiation index (i.e., tropomyosin posi-
tive nuclei/total nuclei) or differentiation marker expression
(Supplemental Fig. S1b), a signiﬁcant decrease in the fusion index
Fig. 1. Gene trap insertion at the Graf1 locus disrupts gene expression. (a) The gene trap vector VICTR48 integrated into the ﬁrst intron of the mouse Graf1 gene. Arrowheads
indicate primer annealing sites for genotype analysis. (b) PCR-based genotyping of isolated tail DNA differentiate wildtype (GRAF1þ /þ) and homozygous mutant (GRAF1gt/gt)
animals by generating fragments of 500 and 280 bp, respectively. DNA from heterozygotes (GRAF1þ /gt) generates both fragments. (c) RT-PCR analysis (top) of GRAF1 cDNA
and Western blot analysis (bottom) of GRAF1 protein from P7 pups conﬁrm reduced expression of GRAF1 in heterozygous (2), and homozygous (3) mutant animals relative to
wildtype littermates (1). GAPDH (cDNA) and γ-tubulin (protein) were used as loading controls. Gastroc.¼Gastrocnemius; Quad.¼Quadriceps femoris; and Diaph.¼
Diaphragm.
K.C. Lenhart et al. / Developmental Biology 393 (2014) 298–311 301
Fig. 2. GRAF1 regulates myoﬁber growth in vivo. (a) Gastrocnemius muscle from 4 month old GRAF1gt/gt mice exhibit smaller myoﬁbers than GRAF1þ /þ mice. Laminin
(green) demarcates myoﬁber boundaries. Nuclei are counterstained with DAPI (blue). (b, c) Frequency histograms of myoﬁber cross-sectional area (CSA) of diaphragm and
gastrocnemius muscle from 4 month old GRAF1þ /þ and GRAF1gt/gt mice. (d, e) Average myoﬁber CSA of diaphragm and gastrocnemius muscle (*po0.05; n¼350 myoﬁbers
per mouse, N¼5 mice per genotype). Data are mean7s.e.m. Scale bars¼100 mm.
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(i.e., the percentage of nuclei present in multinucleated cells) was
observed in GRAFgt/gt compared to GRAF1þ /þ cultures (Fig. 4a–c).
As well, while the cell density (nuclei/area) was not different in
these cultures, the number of nuclei in multinucleated cells was
lower in tropomyosin-positive GRAFgt/gt cells and a concomitant
signiﬁcant reduction in myotube length was observed (Fig. 4d–f).
Fig. 3. GRAF1gt/gt muscles exhibit impaired regenerative capacity (a) Immunohistochemical analysis of GRAF1 expression (red) in uninjured adult gastrocnemius muscle or
muscles 3, 14, and 28 days following cardiotoxin-injection. Nuclei are stained with DAPI (blue). (b) Quantiﬁcation of average nuclear foci per regenerating myoﬁber 14 and 28
days following cardiotoxin injection (*po0.005, **po0.05; n¼250 and n¼500 myoﬁbers per mouse at 14 and 28 days-post injury, respectively; N¼3–5 mice per genotype).
(c) Regenerating gastrocnemius muscle from GRAF1gt/gt mice (14 days following cardiotoxin-induced injury) display fewer regenerating myoﬁbers with 2 (arrowheads) or 3
(asterisks) nuclear foci than injured GRAF1þ /þ muscles. Laminin (green) demarcates myoﬁber boundaries. Nuclei are stained with DAPI (blue). Scale bars¼20 mm.
(d) Quantiﬁcation of the in vivo fusion index for regenerating myoﬁbers 14 and 28 days-post injury (*po0.005, **po0.05; n¼250 and n¼500 myoﬁbers per mouse at 14 and
28 days-post injury, respectively; N¼3–5 mice per genotype). (e) Average CSA of regenerating myoﬁbers 28 days post-injury (*po0.05; n¼350 myoﬁbers per mouse, N¼3–4
mice per genotype). Data are expressed as mean7s.e.m. Scale bars¼100 mM, unless otherwise indicated.
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Collectively, these studies indicate that GRAF1 is necessary for
appropriate myoblast fusion.
GRAF1 regulates golgi to plasma membrane vesicle trafﬁcking
We next examined the mechanism by which GRAF1 promotes
myoblast fusion using C2C12 cells, which are a well-established
multipotent mesenchymal progenitor cell line that undergoes
asynchronous but spontaneous differentiation into multinucleated
skeletal muscle myotubes when cultured under high conﬂuence in
DM (Blau et al., 1985; Yaffe, 1968). In accordance with our previous
ﬁndings (Doherty et al., 2011), GRAF1 is located in discrete actin-
devoid complexes at the tips of differentiated C2C12 myoblasts
undergoing end-to-end alignment/fusion (Fig. 5a). Interestingly,
these GRAF1-labeled regions are also highly enriched in sub-
membranous vesicles as detected by differential interference
contrast (DIC) microscopy (Fig. 5b). Moreover, we found that
GRAF1 co-localized with the early endosomal marker Rab5 within
these pre-fusion complexes but did not co-localize with Lamp2
(a marker for degrading lysosomes), indicating that GRAF1 may be
Fig. 4. GRAF1-depleted myoblast exhibit reduced fusogenic capacity. (a) Representative images of GRAF1þ /þ and GRAF1gt/gt primary cultures immunostained for
tropomyosin (red) at 72 h in differentiation media (DM). F-actin and nuclei are counterstained with phalloidin (green) and DAPI (blue), respectively. (b) GRAF1þ /þ and
GRAF1gt/gt cells immunostained in (4a) exhibited no signiﬁcant difference in their differentiation index (average index for control was 10.5%). Also see Supplemental Fig. S1b
for comparison of skeletal α-actin expression. (c) GRAF1gt/gt cells exhibited a signiﬁcant decrease in their fusion index (*po0.005). (d) Tm-positive GRAF1þ /þ cells were
signiﬁcantly longer than Tm-positive GRAF1gt/gt cells (*po5104). (e) The number of nuclei per ﬁeld was comparable between GRAF1þ /þ and GRAF1gt/gt cultures.
(f) GRAF1gt/gt cells exhibited reduced nuclear accretion with a signiﬁcant increase in mononucleated cells (*po0.005) and decrease in bi-nucleated (**po0.01) and multi-
nucleated (#po0.05) cells in comparison to GRAF1þ /þ controls. At least 1000 Tm-positive cells, 250 myotubes, and 10,000 nuclei were scored over 50 images per genotype
for each assay. Average fusion index for control cells was 1.2%. Data are mean7s.e.m., N¼3 independent experiments. Scale bars¼100 mm.
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a component and/or regulator of endosomal trafﬁcking. In support
of this possibility, we found high levels of GRAF1 in the peri-
nuclear region occupied by the GPI-anchored membrane protein,
Thy-1, which is known to recycle from the endosomes through the
Golgi apparatus and back to the plasma membrane (Fig. 5c and
(Green and Kelly, 1992)).
3-D reconstruction of confocal Z-stacks revealed that GRAF1
enriched regions protruded from the cell surface, and that these
protrusions are localized to the precise point of contact between
fusing myoblasts (Fig. 6a; Supplemental Fig. S3 and S4 and
Supplemental Movie). These ﬁndings are consistent with the
postulate that GRAF1-laden vesicles are recruited to the plasma
membranes of fusing cells and that this process may facilitate cell
to cell adhesion/fusion. In support of a role for GRAF1 in promot-
ing vesicle to plasma membrane trafﬁcking, we found that ectopic
expression of GRAF1 in rounded, proliferating myoblasts induced
membrane protrusions and led to robust surface area expansion,
which necessitates additional membrane recruitment ((Doherty
et al., 2011); Fig. 6b). This phenotype was signiﬁcantly attenuated
by treatment with Brefeldin A (BFA), a drug that inhibits the
translocation of secretory and endocytic recycling vesicles from
the Golgi to the cell membrane, indicating that GRAF1 promotes
plasma membrane expansion by enhancing/facilitating vesicle
recruitment (Fig. 6b,c). To explore a role for this process in the
capacity of GRAF1 to promote myoblast fusion, we utilized our
Cre-inducible GRAF1 cDNA variant (termed GRAF1loxp) that con-
tains a GFP reporter gene (Supplemental Fig. S5 and (Doherty et
al., 2011)). GRAFloxp transfected C2C12 cells were transferred to
DM prior to treatment with either LacZ (control) or Cre adenovirus
to induce GRAF1 expression. Eighteen hours later, subsets of LacZ
or Cre-infected cells were then treated with BFA and nuclear
accretion was assessed 24 h later. As shown in Fig. 6d, GRAF1
expressing cells (in the Cre-treated cultures) exhibited a signiﬁcant
increase in myotube fusion when compared with Lac-Z treated
cells that contained the GRAFloxp construct, consistent with our
previous ﬁndings that GRAF1 promotes cell fusion in pre-
differentiated myoblasts (Doherty et al., 2011). Importantly, BFA
treatment signiﬁcantly reversed the pro-fusogenic capacity of
Fig. 5. GRAF1 is present within endocytic structures in pre-fused myoblasts. (a) Endogenous GRAF1 selectively accumulated within the cytoplasmic bridge (white arrow)
between actively fusing C2C12 myoblasts. (b) GRAF1 co-localizes with intracellular vesicles (arrows) as visualized by DIC microscopy in 48 h differentiated C2C12 myoblasts.
(c) Membrane-associated GRAF1 co-localizes with the early endosomal marker Rab5 (top), but not with Lamp2-positive lysosomes (middle). Peri-nuclear GRAF1 co-localizes
with the endocytic recycling protein Thy-1 (bottom). Nuclei are counterstained with DAPI (blue). Scale bars¼20 mm.
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GRAF1, indicating that GRAF1 promotes fusion of differentiated
myoblasts in a vesicle trafﬁcking-dependent manner.
Supplementary material related to this article can be found
online at doi:10.1016/j.ydbio.2014.06.025.
GRAF1 promotes plasma membrane recruitment of the fusogenic
proteins EHD1, myoferlin, and Fer1L5
The endocytic recycling proteins EHD1 and EHD2 were recently
shown to facilitate myoblast fusion by inducing the release of
vesicles from the endocytic recycling compartment and promoting
subsequent ‘exocytic’ vesicle merging to the plasma membrane
(Cai et al., 2009a; Doherty et al., 2008; Posey et al., 2011a, 2011b).
As shown in Fig. 7a, GRAF1 and EHD1 exhibited remarkable co-
localization in pre-fusion complexes, while little overlap was
observed between GRAF1 and EHD2. This ﬁnding is noteworthy,
because recent studies indicate that EHD2 is primarily localized to
caveolae and unlike depletion of EHD1, depletion of EHD2 does not
block endocytic recycling in ﬁbroblasts (Cai et al., 2013). As EHD1
was previously reported to bind avidly to the fusogenic proteins,
myoferlin and its family member, Fer1L5, and to promote their
transport to the plasma membrane (Doherty et al., 2008; Posey
et al., 2011a, 2011b), we next sought to determine if GRAF1
co-associated with these proteins. Indeed, we observed signiﬁcant
Fig. 6. GRAF1-dependent membrane protrusions and myoblast fusion is dependent on vesicular trafﬁcking. (a) C2C12 cells were treated with DM for 49–72 h, stained for
endogenous GRAF1 (and other indicated antibodies), and visualized by confocal microscopy. Confocal slice views and digital decovolution and 3-D renderings are shown.
GRAF1 is localized to complexes that protrude from cells at pre-fusion complexes (top, also see Supplemental Fig. S2 for confocal slice view) and at the points of cell-cell
contact (middle, white arrows) as demonstrated using image deconvolution of confocal Z-stacks. GRAF1 is localized to the precise point of contact between fusing myoblasts
(bottom, white arrow), note high levels of GRAF1 accumulation in the protrusion of a myoblast that appears to be diving into a GRAF1-labeled region of a myotube. See
Supplemental Fig. S3 for the gallery view of confocal slices of this 6.71 mmmaximum intensity projection (MIP). Myosin heavy chain (MHC) demarcates cell boundaries in top
and middle panels. GM130 demarcates Golgi bodies in bottom panel. (b) Representative images of C2C12 cells maintained in growth media and transfected with Myc-tagged
GRAF1 for 24 h. Twelve hr prior to ﬁxation, cells were treated with (right) or without (left) 0.1 mg/mL Brefeldin A (BFA). Anti-Myc (red) identiﬁes GRAF1 overexpressing cells.
Nuclei are counterstained with DAPI (blue). Scale bars¼50 mm. (c) Quantiﬁcation of the perimeter of cells represented in Fig. 5b demonstrates signiﬁcant reduction in the
plasma membrane surface area of BFA-treated myoblasts (*po1104). (d) C2C12 cells were transfected with a Cre recombinase-inducible Myc-tagged GRAF1 targeting
construct, induced to differentiate for 48 h in DM, and transduced with Cre or control LacZ adenovirus for 36 h. Twenty four hour prior to ﬁxation, cells were treated with
0.3 mg/mL BFA. Dual Myc and DAPI staining were used to quantify the fusion index (*po1104, **po0.005). Average fusion index for control was 6.5%. Data are mean7s.
e.m., n¼75–100 cells per condition, N¼3 independent experiments. Scale bars¼10 mm, unless otherwise indicated.
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co-localization of GRAF1 and myoferlin as well as GRAF1 and
Fer1L5 in pre-fusion complexes in isolated myoblasts and in intact
muscle (Fig. 7a,b). Moreover, myoferlin and GRAF1 exhibited a
strong interaction as assessed by co-immunoprecipitation (Fig. 7c).
We next explored our hypothesis that GRAF1 might facilitate the
recruitment of these proteins to discrete plasma membrane
complexes. Since pre-fusion complexes are more readily observed
in C2C12 cells than in primary myoblast cultures (because the
latter fuse very rapidly in culture), we treated C2C12 cells with
GRAF1 siRNAs (which resulted in a partial reduction of GRAF1
protein; Fig. 7d) and analyzed the localization of Fer1L5, myoferlin
and EHD1 in cells following exposure to DM. As shown in Fig. 7e,
Fer1L5 was no longer localized to foci at the plasma membrane in
GRAF1-deﬁcient cells. Additionally, we observed a signiﬁcant but
incomplete reduction of myoferlin and EHD1 localization to these
sub-plasma membrane structures accompanied by an increase in
perinuclear vesicular staining (Fig. 7e,f). Taken together, these data
indicate that GRAF1 regulates the intracellular trafﬁcking of the
fusogenic ferlin proteins to promote membrane coalescence.
Functional cooperation of GRAF proteins in myoblast fusion
Studies detailed above indicate that loss of GRAF1 renders
myoblast fusion less efﬁcient but does not prevent myotube
formation. Thus we next queried whether other members of the
GRAF family might serve a redundant role in this process. In
mammals, GRAF1 has two closely related family members, GRAF2
and GRAF3. We recently reported that GRAF3 was not expressed in
muscle ﬁbers, but instead was strictly restricted to visceral and
vascular smooth muscle cells (Bai et al., 2013). On the other hand
all three GRAF2 isoforms (Ren et al., 2001) were expressed in peri-
natal muscles, in a temporal fashion that mirrored expression of
Fig. 7. GRAF1 associates with the fusogenic ferlin proteins and promotes recruitment of the endocytic recycling machinery to pre-fusion complexes. (a) C2C12 cells exposed
to DM for 36 h were co-immunostained with GRAF1 and EHD1 (top), EHD2 (top middle), myoferlin (bottom middle) or Fer1L5 (bottom) antibodies. White arrows indicate co-
localization of proteins at pre-fusion sites. High power inset reveals limited co-localization of GRAF1 and EHD2. (b) Tibialis anterior muscle cryo-sections from a 6 month old
wildtype mouse were co-stained with GRAF1 and Fer1L5 antibodies (note sarcolemmal co-localization). (c) Anti-GRAF1 rabbit polyclonal antibody and non-immune sera
(NIS) immunoprecipitations (IP) from C2C12 cells exposed to DM for 72 h. Blots were probed with an anti-myoferlin antibody or hamster anti-GRAF1 antibody. Input contains
20% of cellular lysate used for IP. (d) C2C12 cells transfected with GRAF1-speciﬁc (G1si) or control (NTC) siRNA and exposed to DM for 36 h were lysed and immunoblotted
with GRAF1 antibody to assess knockdown efﬁciency. γ-tubulin is shown as a loading control. (e) C2C12 cells treated as in Fig. 6d were co-stained with GRAF1 and either
Fer1L5 or myoferlin antibodies. GRAF1 and ferlin co-localize at polarized tips in NTC treated cells (arrows), and both Fer1L5 and myoferlin are mis-localized in GRAF1
knockdown cells. (f) C2C12 cells treated as in Fig. 6d were co-stained with EHD1 and Tm antibodies to demarcate differentiated myoblasts. Images illustrate the method of
quantifying EHD1 protein at pre-fusion complexes. ImageJ software was used to measure the intensity of EHD1 signal at a pre-fusion complex (yellow box) relative to the
signal within the rest of the cell. Refer to Fig. 8f for quantiﬁcation. Data are representative of at least 100 cells/condition. Scale bars¼20 mm.
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GRAF1, indicating the possibility that GRAF2 might exhibit func-
tional redundancy and potentially compensate for the loss of
GRAF1 during myotube formation (Fig. 8b). In support of this
possibility, GRAF2 expression was markedly induced upon sub-
jecting C2C12 cells to differentiating conditions (Fig. 8b). More-
over, GRAF2 accumulated into similar peri-nuclear and pre-fusion
complexes (Fig. 8b, bottom) where it co-localizes with myoferlin.
To further explore a role for GRAF2 in muscle fusion, we depleted
GRAF2 from primary GRAF1þ /þ and GRAF1gt/gt myocytes using
validated siRNAs (Fig. 8c). We next subjected these cultures to DM
for 48 h and quantiﬁed nuclear accretion in tropomyosin positive
myoblasts. As shown in Fig. 8d, GRAF2 depletion led to a
signiﬁcant reduction in myoblast-myoblast (bi-nucleated) and
myoblast-myotube fusion (Z3 nuclei). Notably, the lack in fusion
in GRAF2-depleted GRAF1þ /þ cells was even more pronounced
than was observed in myoblasts cultured from GRAF1gt/gt litter-
mates. Moreover, the recruitment of EHD1 to the tips of GRAF2
depleted C2C12 cells was markedly reduced in comparison to
either control or GRAF1-depleted cells (Fig. 8e,f). However, the
depletion of GRAF2 from the GRAF1gt/gt cultures did not result in
Fig. 8. GRAF2 also promotes recruitment of the endocytic recycling machinery to pre-fusion complexes and muscle fusion. (a) Western blot analysis of GRAF1 and GRAF2
protein levels in postnatal (P) and adult (Ad) mouse quadriceps at the indicated time of development. γ-tubulin and Ponceau S-stained blots are shown as loading controls.
(b) Cells exposed to GM and DM for indicated times were immunostained for GRAF2. Note increased expression during C2C12 differentiation and recruitment of GRAF2 to
pre-fusion complexes (arrows). Scale bars¼50 mm. Bottom panels are high magniﬁcation images that reveal co-localization of GRAF2 and myoferlin at the tip of a myoblast
exposed to DM for 48 h. (c) GRAF1þ /þ and GRAF1gt/gt primary myoblasts transfected with GRAF2-speciﬁc or control (NTC) siRNA and exposed to DM for 36 h were assessed
for GRAF2 and GRAF1 expression by reverse transcriptase-PCR. GAPDH is shown as a loading control. (d) GRAF1þ /þ primary myoblasts depleted of GRAF2 by siRNA
knockdown exhibited reduced nuclear accretion in comparison to NTC-treated control GRAF1þ /þ myoblasts. Moreover, depletion of GRAF2 in GRAF1gt/gt cells exhibited a
further reduction in nuclear accretion in comparison to NTC-treated GRAF1þ /þ and GRAF1gt/gt myoblasts (*po1104, **po0.005, #po0.05, n.s.¼not signiﬁcant; n¼300
cells per condition, N¼3 independent experiments). (e) C2C12 cells were transfected with control (NTC), GRAF1-, GRAF2-, or both GRAF1- and GRAF2-speciﬁc siRNAs and
exposed to DM for 36 h before being lysed and immunoblotted with a GRAF2 antibody to assess protein knockdown efﬁciency. γ-tubulin is shown as a loading control.
(f) Quantiﬁcation of the EHD1 ﬂuorescence ratio (refer to Fig. 7f and methods for details) in C2C12 cells transfected with control (NTC), GRAF1-, GRAF2-, or both GRAF1- and
GRAF2-speciﬁc siRNAs that were exposed to DM for 36 h and immunostained for EHD1 and Tm to demarcate differentiated myoblasts (*po0.05, **po0.005; n¼50 cells per
condition, N¼3 independent experiments). Data are mean7s.e.m. Scale bars¼10 mm, unless otherwise indicated.
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an additive fusion defect, possibly due to incomplete knock-down
of this family member or perhaps because these proteins act
together as a functional unit.
Discussion
A clear understanding of the molecular mechanisms that govern
myogenesis is important for the future development of therapies
directed towards ameliorating muscle wasting that occurs with
aging and is exacerbated in muscular dystrophies. We previously
showed that the Rho-GTPase-activating protein, GRAF1, was tran-
siently up-regulated during myogenesis, and that forced expression
of GRAF1 in pre-differentiated myoblasts promoted robust muscle
fusion by a process that required GTPase-activating protein-depen-
dent actin remodeling and BAR-dependent membrane binding or
sculpting. Through the use of our novel GRAF1 depleted mice, we
now show that GRAF1 is essential for efﬁcient myoﬁber growth
in vivo. Post-natal GRAF1gt/gt muscles exhibited a signiﬁcant and
persistent reduction in cross-sectional area and adult muscles had
an impaired capacity to regenerate following injury, suggestive of a
lack of efﬁcient myoblast fusion. Indeed, we found that myoblasts
isolated from GRAF1-depleted mice exhibited impaired myoblast to
myoblast and myoblast to myotube fusion. Our mechanistic studies
reveal that GRAF1 and its related family member, GRAF2, facilitate
myoblast fusion by promoting recruitment of the fusogenic ferlin
proteins to the plasma membrane.
It has become clear that myoblast fusion occurs in a multi-step
fashion in which actin cytoskeletal dynamics and membrane
remodeling play key roles, but questions remain regarding the
spatial/temporal regulation of and interrelationship between these
processes. Over the past several years, studies have revealed that
prior to fusion, differentiated myoblasts assume a bipolar elon-
gated shape that is induced by the interaction of nonmuscle
myosin 2 A with actin at the plasma membrane and that these
so-called F-actin foci mark the future site of myoblast fusion (Duan
and Gallagher, 2009; Peckham, 2008). However, subsequent dis-
solution of the actin focus is essential for cell-cell fusion as
evidenced by the ﬁndings in Drosophila that mutations in known
actin-remodeling genes such as kette, mbc, and SCAR/WAVE all lead
to defective fusion accompanied by enlarged F-actin foci that fail
to dissolve (Schafer et al., 2007; Schroter et al., 2004). The small
GTPase RhoA has been shown to initiate actin polymerization
(Narumiya et al., 1997; Yamana et al., 2006) and we previously
showed that recruitment of the Rho-GAP GRAF1 from the peri-
nuclear region (its sub-cellular locale in proliferating myoblasts) to
the tips of pre-fused bipolar differentiated myoblasts is essential
for limiting Rho-dependent actin polymerization at these sites
(Doherty et al., 2011). One of the potential functions of localized
actin de-polymerization is to facilitate trafﬁcking of intracellular
vesicles to the fusion site. Elegant electron microscopy studies in
Drosophila myoblasts have shown that vesicles accumulate at
juxtaposed inner membranes of fusing cells and that this align-
ment of vesicles is essential for subsequent membrane merging
(Schroter et al., 2004). While the exact nature of these vesicles is
not clear, studies from the McNally laboratory and others indicate
that endocytic recycling vesicles (regulated by EHD1 and EHD2)
are involved and that myoferlin and Fer1L5 are critical fusogenic
cargo carried by these vesicles (Doherty et al., 2008; Posey et al.,
2011a, 2011b). Indeed, expression of a mutant EHD2 that inhibits
endocytic vesicle trafﬁcking led to cytoplasmic sequestration of
ferlins and inhibited myoblast fusion.
Ferlins have been proposed to be important for mediating
plasma membrane ‘capturing’ of intracellular vesicles, though
the precise means by which the subsequent merging of plasma
membranes of two cells is not clear (Posey et al., 2011a). Our
ﬁndings that GRAF1 associates with myoferlin and is co-recruited
to the plasma membrane with EHD1-labeled endocytic vesicles
indicates that GRAF1 is part of this fusogenic complex. Because
GRAF1 functions to accelerate actin de-polymerization, and is
necessary for mediating the recruitment of EHD1 and ferlins to
the plasma membrane, we favor a model in which GRAF1 may
associate with vesicles through its BAR domain and that vesicle-
associated GRAF1 facilitates clearing of sub-plasmalemmal actin to
aid in vesicle capture. In support of this hypothesis, GRAF1
contains a PS-binding PH domain and PS is known to be exposed
on the inner leaﬂets of injured membranes and the outer leaﬂets
of exocytic vesicles (Gerke et al., 2002). Notably, our 3-D recon-
structions of pre-fusion/fusion complexes reveal that the GRAF1-
labeled vesicles are located to regions of the cell membrane that
protrude outward from the cell body. It is likely that GRAF1
facilitates this outward membrane curvature via interactions of
its BAR domain with the inner neck of the membrane protrusion
as has been shown for its F-BAR containing Rho-GAP relative,
srGAP2 (Suetsugu, 2010). Interestingly, GRAF1 protrusions appear
at the point of cell-cell contact of pre-fused cells indicating that
these complexes might function to promote adhesion of two
apposed myoblasts. At this stage, these protrusive complexes
could promote enhanced hydrophobic attractions between the
interiors of the two bilayers, and facilitate lipid transfer from one
membrane to another (Chanturiya et al., 2002; Marrink and Mark,
2003). Buckled membranes also exhibit curvature-induced stress
and thus can accelerate the fusion process by reducing the energy
barrier membranes need to overcome at intermediate stages of
fusion (Martens et al., 2007). While our data strongly support a
model whereby GRAF1 facilitates membrane merging by promot-
ing the recruitment of ferlin-containing vesicles, numerous cell-
surface receptors have been implicated in promoting the initial
stages of myoblast fusion including M-cadherin and NCAM that
mediate cell recognition and integrins that mediate cell-cell
adhesion and it is formally possible that GRAF1-dependent
recruitment of these receptors is involved (Simionescu and
Pavlath, 2011).
Besides specifying the position of cell-cell fusion and promot-
ing membrane contact, GRAF1 may also play an important role in
the late stages of syncytium formation which involves fusion pore
expansion to allow complete coalescence of cytoplasms. In this
ﬁnal stage of cell-cell fusion, initial pores of a few nanometers in
diameter undergo an active expansion to yield a lumen of 10–
15 mm (i.e. the diameter of a typical myoblast). The Chernomordik
laboratory and others have shown that expansion of such pores
that contain strongly bent plasma membrane rims requires per-
sistent energy input and they have postulated that curvature
generating proteins that relax the bending energy of the rim are
likely required to make expansion energetically favorable
(Chernomordik and Kozlov, 2003). BAR domain-containing pro-
teins are likely candidates as these domains form elongated
homodimers characterized by a shallow curvature formed by the
anti-parallel interaction of two α-helical coils that facilitate
membrane deformation (Henne et al., 2007). Previous studies
showed that the GRAF1 BAR domain is capable of inducing
tubulation of spherical lipids and can promote clathrin-
independent endocytosis in ﬁbroblasts and HeLa cells (Eberth
et al., 2009; Lundmark et al., 2008). Interestingly, the curvature
of the membrane at the fusion pore rim and the curvature of
endocytic vesicles are similar, and using an elegant model system
to study the efﬁciency of late stages of cell-cell fusion initiated by
inﬂuenza and baculoviruses, Richard et al. showed that the GRAF1
BAR domain promoted syncytium formation (Richard et al., 2011).
In support of a putative role for GRAF1 in mediating this process
during skeletal muscle cell fusion, we found that GRAF1 protein
accumulates within the narrow neck that joins two fusing
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myoblasts (see Fig. 5a for example). Whether GRAF1 serves to
stabilize the fusion pore and/or to promote endocytosis-
dependent internalization of excess plasma membrane from fusing
cells (Kalderon and Gilula, 1979) are interesting questions for
future studies.
While the loss of GRAF1 clearly makes myoblast fusion less
efﬁcient, muscle development was not completely blocked in
GRAF1gt/gt mice. This ﬁnding indicates that other proteins are
able to compensate for the loss of GRAF1. One attractive candi-
date is GRAF2, a closely related family member that is widely
expressed (Ren et al., 2001). We showed that like GRAF1,
mammalian GRAF2 is also highly up-regulated during skeletal
muscle maturation, and that GRAF2 depletion signiﬁcantly atte-
nuated myoblast-myoblast and myoblast-myotube fusion in WT
primary muscle cell cultures. Moreover, GRAF2 was localized to
similar pre-fusion complexes, and its depletion resulted in a
marked reduction of EHD1 and myoferlin accumulation to these
sites. These data indicate that these family members may have
functionally overlapping roles during muscle development or
may act together as a functional unit. Interestingly, while GRAF1
and GRAF2 exhibit an identical BAR-PH-GAP-SH3 domain struc-
ture, they do have a variable serine/proline region which we
previously showed is a hot-spot for phosphorylation (Taylor et al.,
1998), thus it is possible that these proteins are differentially
regulated by kinase signaling pathways. While we did not see
evidence of GRAF2 overexpression in isolated GRAF1gt/gt myo-
blasts when compared to GRAF1þ /þ cells, we have not ruled out
the possibility that transient up-regulation occurs in developing
GRAFgt/gt muscles. Other classes of BAR domain containing
proteins may also be important for promoting GRAF-
independent muscle fusion. For example, two members of the
Bridging integrator (Bin) family, Bin1 and Bin3 have been shown
to regulate differentiation and fusion of skeletal myoblasts
(Fernando et al., 2009; Simionescu-Bankston et al., 2013;
Wechsler-Reya et al., 1998). Interestingly, while Bin3 is an
N-BAR only containing protein, recent studies indicate that it,
like GRAF1, also regulates actin dynamics. Simionescu-Bankston
et al. recently showed that Bin3 associates with and promotes the
activation of the Rho-related GTPases Cdc42 and Rac1 in myo-
blasts (Simionescu-Bankston et al., 2013). Notably, activation of
these GTPases is often associated with an inhibition of RhoA;
however the effect of Bin3 on RhoA activity was not directly
tested in this model. It will be of interest to determine whether
the Bin proteins also exhibit some functional overlap with the
GRAF proteins or are co-regulated through putative BAR domain
heterodimerization as has been observed in other BAR family
members.
In summary, we provide the ﬁrst evidence that GRAF1 plays an
important role in muscle formation in vivo. The phenotype of the
GRAF1gt/gt mice resembles myoferlin-null mice (Doherty et al.,
2005) and our mechanistic studies reveal that GRAF1 co-associates
with ferlins and regulates the recruitment of these fusogenic
proteins to the plasma membrane. This study furthers our under-
standing of the inter-relationship between cytoskeletal and mem-
brane dynamics during myotube formation.
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